Cargando…
Network Analysis Identifies Drug Targets and Small Molecules to Modulate Apoptosis Resistant Cancers
SIMPLE SUMMARY: With the thriving efficacy of cancers to evolve and evade treatment strategies targeting the apoptosis cell death mechanism, it has become imperative to reorient these conventional cancer therapy methods. In this study, we opted for an in-silico approach to mine the essential non-apo...
Autores principales: | Fathima, Samreen, Sinha, Swati, Donakonda, Sainitin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922238/ https://www.ncbi.nlm.nih.gov/pubmed/33670487 http://dx.doi.org/10.3390/cancers13040851 |
Ejemplares similares
-
Unraveling unique and common cell type-specific mechanisms in glioblastoma multiforme
por: Fathima, Samreen, et al.
Publicado: (2021) -
Virus-host interaction analysis in colorectal cancer identifies core virus network signature and small molecules
por: A.V.S, Sai Krishna, et al.
Publicado: (2022) -
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing
por: Anand, Nithishwer Mouroug, et al.
Publicado: (2021) -
New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells
por: Heinrich, Jörg C., et al.
Publicado: (2016) -
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
por: Luedemann, Max, et al.
Publicado: (2022)